[February 28, 2013]

Research and Markets: Vaccines Partnering Yearbook 2013 Provides Comprehensive Understanding and Unprecedented Access to the Partnering Deals and Agreements

Research and Markets (http://www.researchandmarkets.com/research/vxn82c/vaccines) has announced the addition of the "Vaccines Partnering Yearbook 2013" report to their offering.

The Vaccines Partnering Yearbook 2013 report series provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2012.

Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

The report series also includes numerous tables and figures that illustrate the trends and activities in bigpharma partnering and dealmaking during 2012.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2012.

Vaccine Partnering Yearbook 2013 series is intended to provide the reader with an in-depth understanding and access to partnering trends and structure of deals entered into by leading companies worldwide.

Vaccine Partnering Yearbook 2013 includes:

- Trends in dealmaking in the biopharma industry during 2012

- Comprehensive directory of partnering deals in 2012

- Links to online access to all deals and alliances

- The leading partnering deals by value in 2012

- Most active partnering dealmakers during 2012

In Vaccine Partnering Yearbook 2012 series the partnering deals are listed by:

- Company A-Z

- Headline value

- Stage of development at signing

- Deal component type

- Therapy area

- Technology type

Companies Mentioned:

Abbott

Actavis

Actelion

Allergan

Amgen

Aspen Pharmacare

Astellas

AstraZeneca

Baxter International

Bayer

Biogen Idec

Boehringer Ingelheim

Bristol-Myers Squibb

Celgene

CSL

Daiichi Sankyo

Dainippon Sumitomo

Eisai

Eli Lilly

Endo Pharmaceuticals

Forest Laboratories

Galderma

Gilead Sciences

GlaxoSmithKline

Grifols

Hospira

Johnson & Johnson

Kyowa Hakko Kirin

Lundbeck

Menarini

Merck & Co

Merck KGaA

Mitsubishi (News - Alert) Tanabe

Novartis

Novo Nordisk

Otsuka

Pfizer

Purdue

Roche

Sanofi

Servier

Shionogi

Shire

Takeda

Teva

Valeant

Warner Chilcott

Watson

For more information visit http://www.researchandmarkets.com/research/vxn82c/vaccines

[ Back To Technology News's Homepage ]